Scholars Central

ArticlePublished 4 Jan 2024

Study of the Benefit of Empagliflozin in the Treatment of Acute Decompensated Heart Failure

Authors: Ya Liu, Jing Hu, Guang Xu, Xiuyuan Feng, Chujuan Li

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To examine empagliflozin potential for treating acute decompensated heart failure. 108 acute decompensated heart failure patients who were treated in our hospital from January 2022 to January 2023 were randomly split into two groups, each with 54 patients as research group and the control group. The research group supplemented the control group with empagliflozin, while the control group continued to receive traditional anti-acute decompensated heart failure therapy. Comparisons were made between the two groups clinical effectiveness, cardiac and renal function markers, health status, and follow-up outcomes. The research group’s total treatment effectiveness was better than the control group’s (p 0.05). The research group outperformed the control group in terms of mortality and the risk of re-hospitalization within 60 d (p<0.05). Engramine is a highly valuable therapy option for acute decompensated heart failure since it is efficient, can enhance cardiac function, reduce renal impairment, and improve patient health.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ya Liu”
  • BylineArticles whose byline prints “Jing Hu”
  • BylineArticles whose byline prints “Guang Xu”
  • BylineArticles whose byline prints “Xiuyuan Feng”
  • BylineArticles whose byline prints “Chujuan Li”